Biomarker Assessment of Glutamatergic Target Engagement
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the relative feasibility of 2 potential functional
measures of target engagement (Glx MRS, BOLD fMRI) to systematically assess mGluR 2/3 in drug
development for psychotic spectrum disorders.